Advanced Search

Technical Analysis for NFX - Nuformix Plc

Grade Last Price % Change Price Change
C 1.525 -1.61% -0.03
NFX closed down 1.59 percent on Monday, November 29, 2021, on 32 percent of normal volume.
8 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Down
Historical NFX trend table...
Date Alert Name Type % Chg
Calm After Storm Range Contraction -1.61%
Narrow Range Bar Range Contraction -1.61%
Inside Day Range Contraction -1.61%
Wide Bands Range Expansion -1.61%
Fell Below 20 DMA Bearish -3.17%
Calm After Storm Range Contraction -3.17%
Wide Bands Range Expansion -3.17%
Crossed Above 20 DMA Bullish -7.58%
Stochastic Buy Signal Bullish -7.58%
Pocket Pivot Bullish Swing Setup -7.58%
Older End-of-Day Signals for NFX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 about 3 hours ago
1.5x Volume Pace about 8 hours ago
10 DMA Support about 9 hours ago
Down 3% about 9 hours ago
Down 2% about 9 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators Basic chart:

Profile

Nuformix PLC, formerly Levrett PLC, is a United Kingdom-based pharmaceutical development company. The Company uses cocrystal technology to develop drugs with programs in oncology supportive care and fibrosis. It uses cocrystal technology to re-engineer the crystalline form of drugs. Its clinical pipeline includes NXP001 and NXP002. Its pre-clinical pipeline includes NXP003. It is developing NXP001 for oncology supportive care. It is developing NXP002 for the treatment of multiple fibrotic diseases. NXP003 targets a mechanism understood to confer resistance to immuno-oncology, chemotherapy and radiotherapy cancer treatments.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Pharmaceutical Medicine Pipe Clinic Disease Cancer Radio Diseases Drugs Oncology Therapy Resistance Vr Crystallography Radiotherapy Chemotherapy Fibrosis Cancer Treatments Radiation Therapy

Is NFX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
See more NFX news...

Indicators

Indicator Value
52 Week High 3.63
52 Week Low 1.12
Average Volume 4,328,028
200-Day Moving Average 1.90
50-Day Moving Average 1.42
20-Day Moving Average 1.63
10-Day Moving Average 1.53
Average True Range 0.16
ADX 23.84
+DI 30.28
-DI 14.69
Chandelier Exit (Long, 3 ATRs) 1.47
Chandelier Exit (Short, 3 ATRs) 1.71
Upper Bollinger Bands 1.90
Lower Bollinger Band 1.36
Percent B (%b) 0.36
BandWidth 33.45
MACD Line 0.02
MACD Signal Line 0.04
MACD Histogram -0.0186
Fundamentals Value
Market Cap 7.96 Million
Num Shares 513 Million
EPS -0.40
Price-to-Earnings (P/E) Ratio -3.88
Price-to-Sales 24.97
Price-to-Book 3.03
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.66
Resistance 3 (R3) 1.65 1.61 1.64
Resistance 2 (R2) 1.61 1.58 1.61 1.63
Resistance 1 (R1) 1.58 1.57 1.59 1.59 1.63
Pivot Point 1.54 1.54 1.54 1.54 1.54
Support 1 (S1) 1.51 1.51 1.52 1.52 1.47
Support 2 (S2) 1.47 1.50 1.47 1.47
Support 3 (S3) 1.44 1.47 1.46
Support 4 (S4) 1.45